Check out the companies making the biggest moves in intraday trading: Oracle — The software company’s stock rose more than 3% Thursday after Baird initiated coverage with an outperform rating and a $365 price target. The company said Oracle has a strong position in the artificial intelligence growth story. The stock has been volatile in recent trading as investors debate its prospects. The stock is up 4% through the week. MP Materials — Shares of the rare earth materials maker rose 7%. BMO Capital Markets, in partnership with the Department of Defense, named MP a U.S. “rare earth champion” and resumed coverage with its Market Perform Rating. Meanwhile, China announced it has tightened rare earth export controls ahead of a potential meeting between President Donald Trump and Chinese President Xi Jinping. ALBEMARLE, Lithium Americas — Shares of lithium producers also rose as China considers requiring export permits for some types of lithium-ion batteries. Albemarle rose 7% and Lithium Americas rose about 3%. Tilray Brands — Shares of the cannabis company rose about 24% after reporting first-quarter earnings on the back of better-than-expected profits. Ferrari — The luxury carmaker fell 14% after lowering its electrification target. Ferrari said it expects its 2030 sports car model lineup to be 40% internal combustion engine, 40% hybrid and 20% fully electric. This was below the previous goal of increasing EV sales by 40% by the end of 2010. Delta Air Lines — Shares rose nearly 5% after the airline issued strong guidance and reported third-quarter results that beat analysts’ expectations. The company had revenue of $15.2 billion and adjusted earnings per share of $1.71. Analyst estimates compiled by LSEG were for sales of $15.06 billion and earnings per share of $1.53. Rival United Airlines also added 3% to its price following Delta’s report. Akello Therapeutics — The biopharmaceutical company rose nearly 17% after announcing it would be acquired by Novo Nordisk for $54 per share, or $4.7 billion in cash. Akello manufactures a drug aimed at treating steatohepatitis associated with metabolic dysfunction (MASH). The company’s efluxifermine drug EFX is in Phase 3 trials. Novo Nordisk shares fell more than 1%. PepsiCo — The snack and beverage giant rose about 3% after reporting third-quarter results that beat analysts’ expectations. The company had adjusted earnings per share of $2.29 and revenue of $23.94 billion. Analysts had expected earnings of $2.26 per share on sales of $23.83 billion, according to LSEG. OKRO — The stock rose nearly 3% after Canaccord Genuity initiated coverage of a buy rating on the nuclear technology company. The company anticipates strong long-term demand for nuclear energy, with Okro emerging as a leader. Azz — Shares fell more than 3% after the hot-dip galvanizing and coil coating solutions provider reported lower-than-expected second-quarter earnings and sales. As said demand is weak in several end markets. —CNBC’s Michelle Fox, Fred Imbert, Alex Harring, Sarah Min and Liz Napolitano contributed reporting (Learn the best strategies for 2026 from inside the New York Stock Exchange with Josh Brown and more on CNBC PRO Live. Tickets and information here ).
